Thero2-01S22 in HER2-positive Breast Cancer
Clinical trial NCT05698186 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05698186
- Sponsor
- Institut de cancérologie Strasbourg Europe
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-15
- Primary completion
- 2027-05-15
- Enrollment
- 320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.